General Information of Drug (ID: DMFOBM9)

Drug Name
4,5,6,7-tetrahydrofuro[3,4-c]pyridine-1(3H)-one derivative 3
Synonyms PMID27788040-Compound-2b
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 424.6
Logarithm of the Partition Coefficient (xlogp) 3.5
Rotatable Bond Count (rotbonds) 6
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C26H36N2O3
IUPAC Name
5-[3-(azepan-1-yl)propanoyl]-3-(2-methylpropyl)-3-phenyl-6,7-dihydro-4H-furo[3,4-c]pyridin-1-one
Canonical SMILES
CC(C)CC1(C2=C(CCN(C2)C(=O)CCN3CCCCCC3)C(=O)O1)C4=CC=CC=C4
InChI
InChI=1S/C26H36N2O3/c1-20(2)18-26(21-10-6-5-7-11-21)23-19-28(17-12-22(23)25(30)31-26)24(29)13-16-27-14-8-3-4-9-15-27/h5-7,10-11,20H,3-4,8-9,12-19H2,1-2H3
InChIKey
GPTJWUZEJKIMBY-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
89615787
TTD ID
D06TFC

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Neuropeptide S receptor (NPSR) TTV1C0Z NPSR1_HUMAN Antagonist [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Neuropeptide S receptor ligands: a patent review (2005-2016).Expert Opin Ther Pat. 2017 Mar;27(3):347-362.